[Breast scintigraphy].
Prats
E
E
Servicio de Medicina Nuclear. Hospital Clínico Universitario. Zaragoza.
Razola
P
P
García López
F
F
Dolores Abós
M
M
Banzo
J
J
D000328:Adult; D016477:Artifacts; D001365:Axilla; D001706:Biopsy; D001941:Breast Diseases / Q000000981:diagnostic imaging / Q000473:pathology; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D002277:Carcinoma / Q000000981:diagnostic imaging; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging; D017024:Chemotherapy, Adjuvant; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005189:False Positive Reactions; D005260:Female; D005544:Forecasting; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008279:Magnetic Resonance Imaging; D008327:Mammography; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009378:Neoplasms, Multiple Primary / Q000000981:diagnostic imaging; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D018579:Patient Selection; D011877:Radionuclide Imaging / Q000295:instrumentation; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000493:pharmacokinetics; D013669:Technetium Tc 99m Medronate; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics; D013794:Thallium Radioisotopes; D014463:Ultrasonography
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D013794:Thallium Radioisotopes; C078700:technetium tc-99m tetrofosmin; D017256:Technetium Tc 99m Sestamibi; D013669:Technetium Tc 99m Medronate